The latest closing stock price for CytoMed Therapeutics as of November 20, 2024 is 2.21.
An investor who bought $1,000 worth of CytoMed Therapeutics stock at the IPO in 2023 would have $-447 today, roughly 0 times their original investment - a -25.67% compound annual growth rate over 2 years.
The all-time high CytoMed Therapeutics stock closing price was 5.64 on July 11, 2023.
The CytoMed Therapeutics 52-week high stock price is 5.50, which is 148.9% above the current share price.
The CytoMed Therapeutics 52-week low stock price is 1.20, which is 45.7% below the current share price.
The average CytoMed Therapeutics stock price for the last 52 weeks is 2.40.
An investor who bought $1,000 worth of CytoMed Therapeutics stock at the IPO in 2023 would have $-447 today, roughly 0 times their original investment - a -25.67% compound annual growth rate over 2 years.
The all-time high CytoMed Therapeutics stock closing price was 5.64 on July 11, 2023.
The CytoMed Therapeutics 52-week high stock price is 5.50, which is 148.9% above the current share price.
The CytoMed Therapeutics 52-week low stock price is 1.20, which is 45.7% below the current share price.
The average CytoMed Therapeutics stock price for the last 52 weeks is 2.40.